{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:12:55Z","timestamp":1792134775391,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Drug development and disease prevention of heart failure (HF) and atrial fibrillation (AF) are impeded by a lack of robust early-stage surrogates. We determined to what extent cardiac magnetic resonance (CMR) measurements act as surrogates for the development of HF or AF.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Genetic data were sourced on the association with 21 atrial and ventricular CMR measurements. Mendelian randomization was used to determine CMR associations with AF, HF, non-ischaemic cardiomyopathy (NICM), and dilated cardiomyopathy (DCM), noting that the definition of NICM includes DCM as a subset. Additionally, for the CMR surrogates of AF and HF, we explored their association with non-cardiac traits potentially influenced by cardiac disease liability.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In total we find that 7 CMR measures (biventricular ejection fraction (EF) and end-systolic volume (ESV), as well as LV systolic volume (SV), end-diastolic volume (EDV), and mass to volume ratio (MVR)) associate with the development of HF, 5 with the development of NICM (biventricular EDV and ESV, LV-EF), 7 with DCM (biventricular EF, ESV, EDV, and LV end-diastolic mass (EDM), and 3 associate with AF (LV-ESV, RV-EF, RV-ESV). Higher EF of both ventricles associate with lower risk of HF and DCM, with biventricular ESV associating with all four cardiac outcomes. Higher values of biventricular EDV associate with lower risk of HF, and DCM. Exploring the associations of these CMR cardiac disease surrogates with non-cardiac traits confirms a strong link with diastolic blood pressure, as well as more specific associations with lung function (LV-ESV), HbA1c (LV-EDM), and type 2 diabetes (LV-SV).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The current paper identifies key CMR measurements that may act as surrogate endpoints for the development of HF (including NICM and DCM) or AF.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1038\/s43856-025-00855-1","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T07:37:23Z","timestamp":1745048243000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Mendelian randomization analysis of cardiac MRI measurements as surrogate outcomes for heart failure and atrial fibrillation"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1327-0424","authenticated-orcid":false,"given":"A. F.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3319-1937","authenticated-orcid":false,"given":"C.","family":"Finan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4934-7510","authenticated-orcid":false,"given":"J.","family":"van Setten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Puyol-Ant\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Ruijsink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bourfiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1450-2936","authenticated-orcid":false,"given":"A. I.","family":"Alasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. K.","family":"Velthuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. W.","family":"Asselbergs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S. J. M.","family":"te Riele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,19]]},"reference":[{"key":"855_CR1","doi-asserted-by":"publisher","first-page":"l223","DOI":"10.1136\/bmj.l223","volume":"364","author":"CJ Taylor","year":"2019","unstructured":"Taylor, C. J. et al. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study. BMJ 364, l223 (2019).","journal-title":"BMJ"},{"key":"855_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1161\/CIRCHEARTFAILURE.110.957480","volume":"4","author":"DS Lee","year":"2011","unstructured":"Lee, D. S. et al. A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction. Circ. Heart Fail 4, 36\u201343 (2011).","journal-title":"Circ. Heart Fail"},{"key":"855_CR3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/eurheartj\/ehaa1077","volume":"42","author":"BM Al-Khayatt","year":"2021","unstructured":"Al-Khayatt, B. M. et al. Paradoxical impact of socioeconomic factors on outcome of atrial fibrillation in Europe: trends in incidence and mortality from atrial fibrillation. Eur. Heart J. 42, 847\u2013857 (2021).","journal-title":"Eur. Heart J."},{"key":"855_CR4","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.108.821306","volume":"119","author":"E Anter","year":"2009","unstructured":"Anter, E., Jessup, M. & Callans, D. J. Atrial Fibrillation and Heart Failure. Circulation 119, 2516\u20132525 (2009).","journal-title":"Circulation"},{"key":"855_CR5","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1056\/NEJMoa1510774","volume":"373","author":"MM Redfield","year":"2015","unstructured":"Redfield, M. M. et al. Isosorbide mononitrate in heart failure with preserved ejection fraction. N. Engl. J. Med. 373, 2314\u20132324 (2015).","journal-title":"N. Engl. J. Med."},{"key":"855_CR6","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1001\/jama.2015.15734","volume":"314","author":"M Gheorghiade","year":"2015","unstructured":"Gheorghiade, M. et al. Effect of Vericiguat, a Soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction: The SOCRATES-REDUCED Randomized Trial. JAMA 314, 2251\u20132262 (2015).","journal-title":"JAMA"},{"key":"855_CR7","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.jacc.2015.03.016","volume":"65","author":"CB Fordyce","year":"2015","unstructured":"Fordyce, C. B. et al. Cardiovascular drug development: is it dead or just hibernating? J. Am. Coll. Cardiol. 65, 1567\u20131582 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"855_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add4984","volume":"9","author":"AF Schmidt","year":"2023","unstructured":"Schmidt, A. F. et al. Druggable proteins influencing cardiac structure and function: Implications for heart failure therapies and cancer cardiotoxicity. Sci. Adv. 9, eadd4984 (2023).","journal-title":"Sci. Adv."},{"key":"855_CR9","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1093\/eurheartj\/ehab466","volume":"42","author":"G Ahlberg","year":"2021","unstructured":"Ahlberg, G. et al. Genome-wide association study identifies 18 novel loci associated with left atrial volume and function. Eur. Heart J. 42, 4523\u20134534 (2021).","journal-title":"Eur. Heart J."},{"key":"855_CR10","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","volume":"44","author":"E Arbelo","year":"2023","unstructured":"Arbelo, E. et al. 2023 ESC Guidelines for the management of cardiomyopathies. Eur. Heart J. 44, 3503\u20133626 (2023).","journal-title":"Eur. Heart J."},{"key":"855_CR11","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","volume":"37","author":"YM Pinto","year":"2016","unstructured":"Pinto, Y. M. et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur. Heart J. 37, 1850\u20131858 (2016).","journal-title":"Eur. Heart J."},{"key":"855_CR12","doi-asserted-by":"publisher","unstructured":"Wu, K.-H. H. et al. Polygenic risk score from a multi-ancestry GWAS uncovers susceptibility of heart failure. 2021.12.06.21267389 Preprint at https:\/\/doi.org\/10.1101\/2021.12.06.21267389 (2021).","DOI":"10.1101\/2021.12.06.21267389"},{"key":"855_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1161\/CIRCULATIONAHA.118.035774","volume":"139","author":"KG Aragam","year":"2019","unstructured":"Aragam, K. G. et al. Phenotypic refinement of heart failure in a National Biobank facilitates genetic discovery. Circulation 139, 489\u2013501 (2019).","journal-title":"Circulation"},{"key":"855_CR14","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1093\/eurheartj\/ehab030","volume":"42","author":"S Garnier","year":"2021","unstructured":"Garnier, S. et al. Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23. Eur. Heart J. 42, 2000\u20132011 (2021).","journal-title":"Eur. Heart J."},{"key":"855_CR15","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41588-018-0171-3","volume":"50","author":"JB Nielsen","year":"2018","unstructured":"Nielsen, J. B. et al. Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. Nat. Genet. 50, 1234\u20131239 (2018).","journal-title":"Nat. Genet."},{"key":"855_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-022-05165-3","volume":"611","author":"A Mishra","year":"2022","unstructured":"Mishra, A. et al. Stroke genetics informs drug discovery and risk prediction across ancestries. Nature 611, 115\u2013123 (2022).","journal-title":"Nature"},{"key":"855_CR17","doi-asserted-by":"publisher","first-page":"100192","DOI":"10.1016\/j.xgen.2022.100192","volume":"2","author":"W Zhou","year":"2022","unstructured":"Zhou, W. et al. Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease. Cell Genom. 2, 100192 (2022).","journal-title":"Cell Genom."},{"key":"855_CR18","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/s41588-018-0205-x","volume":"50","author":"E Evangelou","year":"2018","unstructured":"Evangelou, E. et al. Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat. Genet. 50, 1412\u20131425 (2018).","journal-title":"Nat. Genet."},{"key":"855_CR19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/hmg\/ddy327","volume":"28","author":"SL Pulit","year":"2019","unstructured":"Pulit, S. L. et al. Meta-analysis of genome-wide association studies for body fat distribution in 694,649 individuals of European ancestry. Hum. Mol. Genet. 28, 166\u2013174 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"855_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41588-018-0084-1","volume":"50","author":"A Mahajan","year":"2018","unstructured":"Mahajan, A. et al. Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes. Nat. Genet. 50, 559\u2013571 (2018).","journal-title":"Nat. Genet."},{"key":"855_CR21","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ajhg.2018.09.009","volume":"103","author":"S Ligthart","year":"2018","unstructured":"Ligthart, S. et al. Genome Analyses of >200,000 Individuals Identify 58 Loci for chronic inflammation and highlight pathways that link inflammation and complex disorders. Am. J. Hum. Genet. 103, 691\u2013706 (2018).","journal-title":"Am. J. Hum. Genet."},{"key":"855_CR22","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/s41588-019-0407-x","volume":"51","author":"M Wuttke","year":"2019","unstructured":"Wuttke, M. et al. A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat. Genet. 51, 957\u2013972 (2019).","journal-title":"Nat. Genet."},{"key":"855_CR23","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen, I. E. et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat. Genet. 51, 404\u2013413 (2019).","journal-title":"Nat. Genet."},{"key":"855_CR24","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/gepi.22077","volume":"41","author":"S Burgess","year":"2017","unstructured":"Burgess, S., Zuber, V., Valdes-Marquez, E., Sun, B. B. & Hopewell, J. C. Mendelian randomization with fine-mapped genetic data: Choosing from large numbers of correlated instrumental variables. Genet. Epidemiol. 41, 714\u2013725 (2017).","journal-title":"Genet. Epidemiol."},{"key":"855_CR25","doi-asserted-by":"publisher","unstructured":"Hemani, G., Tilling, K. & Davey Smith, G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. (2017) https:\/\/doi.org\/10.1371\/journal.pgen.1007081.","DOI":"10.1371\/journal.pgen.1007081"},{"key":"855_CR26","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden, J., Smith, G. D. & Burgess, S. Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int J. Epidemiol. 44, 512\u2013525 (2015).","journal-title":"Int J. Epidemiol."},{"key":"855_CR27","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/sim.7221","volume":"36","author":"J Bowden","year":"2017","unstructured":"Bowden, J. et al. A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat. Med. 36, 1783\u20131802 (2017).","journal-title":"Stat. Med."},{"key":"855_CR28","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1093\/ije\/dyy101","volume":"47","author":"J Bowden","year":"2018","unstructured":"Bowden, J. et al. Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression. Int J. Epidemiol. 47, 1264\u20131278 (2018).","journal-title":"Int J. Epidemiol."},{"key":"855_CR29","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden, J., Davey-Smith, G., Haycock, P. C. & Burgess, S. Consistent estimation in Mendelian randomization withsome invalid instruments using a weighted median estimator. Genet. Epidemiol. 40, 304\u201314 (2016).","journal-title":"Genet. Epidemiol."},{"key":"855_CR30","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1093\/ije\/dyx254","volume":"47","author":"AF Schmidt","year":"2018","unstructured":"Schmidt, A. F. & Dudbridge, F. Mendelian randomization with Egger pleiotropy correction and weakly informative Bayesian priors. Int. J. Epidemiol. 47, 1217\u20131228 (2018).","journal-title":"Int. J. Epidemiol."},{"key":"855_CR31","doi-asserted-by":"crossref","unstructured":"Burgess, S., Davies, N. M. & Thompson, S. G. Bias due to participant overlap in two-sample Mendelian randomization. Genetic Epidemiology. 40, 597\u2013608 (2016).","DOI":"10.1002\/gepi.21998"},{"key":"855_CR32","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/1467-9868.00346","volume":"64","author":"JD Storey","year":"2002","unstructured":"Storey, J. D. A direct approach to false discovery rates. J. R. Stat. Soc. Ser. B: Stat. Methodol. 64, 479\u2013498 (2002).","journal-title":"J. R. Stat. Soc. Ser. B: Stat. Methodol."},{"key":"855_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09572-5","volume":"10","author":"Y Wu","year":"2019","unstructured":"Wu, Y. et al. Genome-wide association study of medication-use and associated disease in the UK Biobank. Nat. Commun. 10, 1891 (2019).","journal-title":"Nat. Commun."},{"key":"855_CR34","doi-asserted-by":"publisher","first-page":"f6745","DOI":"10.1136\/bmj.f6745","volume":"347","author":"L Shen","year":"2013","unstructured":"Shen, L. et al. Role of diuretics, \u03b2 blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study. BMJ 347, f6745 (2013).","journal-title":"BMJ"},{"key":"855_CR35","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","volume":"385","author":"DI Swerdlow","year":"2015","unstructured":"Swerdlow, D. I. et al. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet 385, 351\u2013361 (2015).","journal-title":"Lancet"},{"key":"855_CR36","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1093\/ije\/dyu187","volume":"43","author":"RJ Silverwood","year":"2014","unstructured":"Silverwood, R. J. et al. Testing for non-linear causal effects using a binary genotype in a Mendelian randomization study: application to alcohol and cardiovascular traits. Int J. Epidemiol. 43, 1781\u20131790 (2014).","journal-title":"Int J. Epidemiol."},{"key":"855_CR37","doi-asserted-by":"crossref","unstructured":"Staley, J. R. & Burgess, S. Semiparametric methods for estimation of a nonlinear exposure-outcome relationship using instrumental variables with application to Mendelian randomization. Genet. Epidemiol. 41, 341\u2013352 (2017).","DOI":"10.1002\/gepi.22041"},{"key":"855_CR38","doi-asserted-by":"publisher","unstructured":"A Mendelian randomization analysis of cardiac MRI measurements as surrogate outcomes for heart failure and atrial fibrillation. https:\/\/doi.org\/10.5522\/04\/28639193.","DOI":"10.5522\/04\/28639193"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00855-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00855-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00855-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T07:37:24Z","timestamp":1745048244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00855-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,19]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["855"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-00855-1","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,19]]},"assertion":[{"value":"21 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: AFS and FWA have received Servier funding for unrelated work. AFS and CF have received funding from NewAmsterdam Pharma for unrelated work. AFS is an Editorial Board Member for Communications Medicine but was not involved in the editorial review or peer review, nor in the decision to publish this article. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"130"}}